Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on ...

The combination of two cancer drugs, rapamycin and trametinib, can extend the lifespan of mice by 30%, according to a study ...

Jefferies, BofA Securities, Piper Sandler and Barclays are acting as joint book-running managers for the proposed offering.

Scientists at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard have re-engineered ...

Parasitic worms that infect humans are not interbreeding with those that infect cattle as previously thought. This is good ...

Recent research points to the potential utility of a familiar sounding foe–herpes virus–in the fight against cancer.

Gene delivery systems can target specific brain cells, a breakthrough that could lead to treatments for Parkinson's, ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

A team of scientists from the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, has identified a ...

Readers respond to an article about gene editing and object to cuts in research funding. Also: The Covid vaccine; Senator ...

Jim Wilson‘s pioneering gene therapy explorations have helped launch eight companies focused on translating his 40 years of ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...